BMRN– BioMarin Pharmaceutical Inc evelops and commercializes pharmaceuticals for various diseases and medical conditions.

BMRN– BioMarin Pharmaceutical Inc

Fundamentals Previously closed at 89.65
Day’s high 91.26
Day’s low 88.94
P/E ratio NA
EPS -1.18

 

Analysts opinion BioMarin is a specialist in rare-disease specialist. The controversial drug Kyndrisa, which intended to treat Duchenne muscular dystrophy was rejected by the Committee for Medical Products for Human Use (CHMP). Analyst confidence meter, a proprietary algorithm of Stockal gives 89% buy based on analyst ratings.
Sentiments The sentiment index is 50% positive according to Stockal proprietary algorithm.
NA Media Pulse The stock has 64% higher social media chatter than usual.

CRM – Salesforce.com Inc is a provider of enterprise cloud computing solutions, with a focus on customer relationship management.

CRM – Salesforce.com Inc

Fundamentals Previously closed at 83.71
Day’s high 84.06
Day’s low 83.16
P/E ratio NA
EPS -0.02

 

Analyst opinion Salesforce announced that it would buy e-commerce specialist Demandware in a $2.8 Billion deal. Salesforce President Keith Block said that the new E-commerce cloud will join Salesforce’s existing Sales, Marketing, Service and the upcoming IoT clouds.  Confidence Meter reads a 75% buy. This a proprietary algorithm of Stockal tracks Analyst confidence in the Stock.
Sentiments The sentiment index is 100% positive on Stockal proprietary algorithm.
Social Media Pulse The stock has 54% higher social chatter than usual.

Disclaimer: This blog contains an aggregated view of analysts and opinions by the author. Do not consider this as financial advice. See http://stockal.com/legalities/

Leave a Reply

Your email address will not be published. Required fields are marked *